Viblac Pharma Private Limited
About Viblac Pharma Private Limited
Data last updated:
Viblac Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 28 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC330176. Its GSTIN is 10AAGCV3070L1ZF (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mukesh Kumar Chaudhary and Rashmi Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 573 3rd Floor Ws – 3 Main Road Chirag Delhi, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2022, the company reported a revenue of ₹3.26 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net loss of ₹21,519 (net margin -6.6%) and EBITDA of -₹1.6 Lakh (EBITDA margin -49.1%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
Company details
Contact details
Viblac Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address573 3rd Floor Ws – 3 Main Road Chirag Delhi, New Delhi, Delhi, India – 110017
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Viblac Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Viblac Pharma Private Limited
FY 2024 filings availableViblac Pharma Private Limited reported revenue of ₹3.26 Lakh (up 27% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 27% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 10%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.26 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹21,519 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -49.1% | ||||
| Net Profit Margin | -6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Viblac Pharma Private Limited, buy the company report.
Board of directors of Viblac Pharma Private Limited
Viblac Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Chaudhary | Director | 28 Feb 2018 | 8 Years 7 Months | Current |
| Rashmi Agrawal | Director | 28 Feb 2018 | 8 Years 7 Months | Current |
| Vivek Dukhan Kumar | Director | 28 Feb 2018 | 8 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Viblac Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Viblac Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Viblac Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCV3070L1ZF | Bihar | Active | 24 May 2018 |
To see the full GST registrations and return filing status of Viblac Pharma Private Limited, buy the company report.
Recent activity
Viblac Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Mukesh Kumar Chaudhary was appointed as Director on 28 Feb 2018.
Frequently asked questions
Viblac Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 28 February 2018 (8+ years old) and is registered under CIN U74999DL2018PTC330176.
Viblac Pharma has 3 current directors:
- Mukesh Kumar Chaudhary - Director
- Rashmi Agrawal - Director
- Vivek Dukhan Kumar - Director
The latest financial statements of Viblac Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Viblac Pharma is 10AAGCV3070L1ZF, registered in Bihar.
The CIN (Corporate Identification Number) of Viblac Pharma is U74999DL2018PTC330176. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Viblac Pharma was incorporated on 28 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Mukesh Kumar Chaudhary was appointed as Director on 28 Feb 2018. Rashmi Agrawal was appointed as Director on 28 Feb 2018. Vivek Dukhan Kumar was appointed as Director on 28 Feb 2018.
The registered office of Viblac Pharma is at 573 3rd Floor Ws – 3 Main Road Chirag Delhi, New Delhi, Delhi, India – 110017.
Viblac Pharma operates in the business services industry, in the other services segment.
Viblac Pharma can be reached at its registered office: 573 3rd Floor Ws – 3 Main Road Chirag Delhi, New Delhi, Delhi, India – 110017.